Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies
Series: Advances in Cancer Research; 161;
- Publisher's listprice EUR 122.00
-
51 752 Ft (49 288 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 175 Ft off)
- Discounted price 46 577 Ft (44 359 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
51 752 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Academic Press
- Date of Publication 29 July 2024
- ISBN 9780443296284
- Binding Hardback
- No. of pages498 pages
- Size 228x152 mm
- Weight 450 g
- Language English 608
Categories
Long description:
Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies, Volume 161 in the Advances in Cancer Research series, covers timely topics such as The Prostate Cancer Tissue N-glycome as a Source of Biomarkers, a Progression from Normal to Metastatic Disease, Multiplexed Targeted Proteomics for Prostate Cancer Biomarker Verification, MRI for the Detection of Clinically Significant Prostate Cancer: Update and Future Directions, Genetic and epigenetic factors for prostate cancer progression, Epigenetic regulation of androgen dependent and independent prostate cancer, Molecular Landscape of Prostate Cancer Bone Metastasis, Future of radioligand Therapy in PC, and more.
Additional chapters of note include Advancements in Computer Vision and Pathology: Unraveling the Potential of Artificial Intelligence for Precision Diagnosis and Beyond and Extracellular Vesicles in Prostate Cancer.
Table of Contents:
1. The Prostate Cancer Tissue N-glycome as a Source of Biomarkers, a Progression from Normal to Metastatic Disease
2. Multiplexed Targeted Proteomics for Prostate Cancer Biomarker Verification
3. MRI for the Detection of Clinically Significant Prostate Cancer: Update and Future Directions
4. Genetic and epigenetic factors for prostate cancer progression
5. Epigenetic regulation of androgen dependent and independent prostate cancer
6. Molecular Landscape of Prostate Cancer Bone Metastasis
7. Future of radioligand Therapy in PC
8. Advancements in Computer Vision and Pathology: Unraveling the Potential of Artificial Intelligence for Precision Diagnosis and Beyond
9. Extracellular Vesicles in Prostate Cancer
The BFG
6 623 HUF
5 630 HUF
Lanzarote - 1.000 Teile (Puzzle)
13 956 HUF
13 258 HUF
